Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody With Occurrence of Nonvalvular Atrial Fibrillation

被引：0
作者：
Hu, Bing
Sun, Yanxiang
Li, Sha
Sun, Jie
Liu, Tong
Wu, Zidi
Feng, Li
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Atrial fibrillation; Autonomic nervous system; Immune system; Inflammation and inflammatory markers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11153
引用
收藏
页数：2
相关论文
共 41 条
  • [21] Association of atrial fibrillation with gene polymorphisms of connexin 40 and angiotensin II receptor type 1 in Chongming adults of Shanghai
    Hou, Shuxin
    Lu, Yingmin
    Huang, Damin
    Luo, Xiaohan
    Yue, Dongmei
    Zhang, Jinchun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (07): : 11803 - 11810
  • [22] Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation
    Chiang, David Y.
    Li, Na
    Wang, Qiongling
    Alsina, Katherina M.
    Quick, Ann P.
    Reynolds, Julia O.
    Wang, Guoliang
    Skapura, Darlene
    Voigt, Niels
    Dobrev, Dobromir
    Wehrens, Xander H. T.
    [J]. CARDIOVASCULAR RESEARCH, 2014, 103 (01) : 178 - 187
  • [23] Oroxin B Resembles Bisoprolol in Attenuating Beta1-Adrenergic Receptor Autoantibody-Induced Atrial Remodelling via the PTEN/AKT/mTOR Signalling Pathway
    Yang, Na
    Sun, Huaxin
    Xi, Linqiang
    Zhang, Ling
    Lu, Yanmei
    Wang, Qianhui
    Cao, Jiaru
    Song, Jie
    Tang, Baopeng
    Shang, Luxiang
    Zhou, Xianhui
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2025, 52 (02)
  • [24] Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy
    Yin-Jian Yang
    Jin-Qing Yuan
    Chao-Mei Fan
    Jie-Lin Pu
    Pi-Hua Fang
    Jian Ma
    Xi-Ying Guo
    Yi-Shi Li
    [J]. Heart and Vessels, 2016, 31 : 1148 - 1153
  • [25] Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma
    Denas, Gentian
    Zoppellaro, Giacomo
    Jose, Seena Padayattil
    Antonucci, Emilia
    Marongiu, Francesco
    Poli, Daniela
    Testa, Sophie
    Tripodi, Armando
    Palareti, Gualtiero
    Pengo, Vittorio
    [J]. CARDIOVASCULAR THERAPEUTICS, 2018, 36 (01)
  • [26] 2-Aminoethoxydiphenyl borate, a inositol 1,4,5-triphosphate receptor inhibitor, prevents atrial fibrillation
    Xiao, Junjie
    Liang, Dandan
    Zhao, Hong
    Liu, Ying
    Zhang, Hong
    Lu, Xiaowei
    Liu, Yi
    Li, Jun
    Peng, Luying
    Chen, Yi-Han
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 235 (07) : 862 - 868
  • [27] Association of glucagon-like peptide-1 receptor agonists with atrial fibrillation, cardiac arrest, and ventricular fibrillation: Casual evidence from a drug target Mendelian randomization
    Xinyi Zhang
    Nanqin Peng
    Xiaoyue Zhang
    Zicheng Zhu
    Yan Miao
    Yuting Wu
    Jitao Ling
    Chen Li
    Wenli Gu
    Jing Zhang
    Abudukeremu Ayiguli
    Ziheng Zheng
    Peng Yu
    Xiao Liu
    [J]. Diabetology & Metabolic Syndrome, 17 (1)
  • [28] The role of Toll-like receptor 2 and hypoxia-induced transcription factor-1α in the atrial structural remodeling of non-valvular atrial fibrillation
    Xu, Yanmin
    Sharma, Deepak
    Du, Fawang
    Liu, Yuzhi
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2940 - 2941
  • [29] m6A reader YTHDF2 governs the onset of atrial fibrillation by modulating Cacna1c translation
    Chen, Chuansheng
    Wang, Guanghua
    Zou, Qicheng
    Xiong, Ke
    Chen, Zhiwen
    Shao, Beihua
    Liu, Yi
    Xie, Duanyang
    Ji, Yong
    [J]. SCIENCE CHINA-LIFE SCIENCES, 2025, 68 (03) : 706 - 721
  • [30] SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation
    Chan, Yi-Hsin
    Chao, Tze-Fan
    Chen, Shao-Wei
    Lee, Hsin-Fu
    Li, Pei-Ru
    Yeh, Yung-Hsin
    Kuo, Chi-Tai
    See, Lai-Chu
    Lip, Gregory Y. H.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (10) : 2617 - 2629
12345